#BEGIN_DRUGCARD DB01895

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C14H19N6O10P

# Chemical_IUPAC_Name:
(3S)-3-amino-4-[({[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]-4-oxobutanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Aspartyl-Adenosine-5'-Monophosphate

# HET_ID:
AMO

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C14H19N6O10P/c15-5(1-7(21)22)14(25)30-31(26,27)28-2-6-9(23)10(24)13(29-6)20-4-19-8-11(16)17-3-18-12(8)20/h3-6,9-10,13,23-24H,1-2,15H2,(H,21,22)(H,26,27)(H2,16,17,18)/t5-,6-,9-,10+,13+/m0/s1

# InChI_Key:
InChIKey=QPBSGQWTJLPZNF-OQIRQZMPSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1895

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
462.3086

# Molecular_Weight_Mono:
462.09002737

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1G51

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.3

# Predicted_LogS:
-2.2

# Predicted_Water_Solubility:
2.59e+00 g/l

# Primary_Accession_No:
DB01895

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936251

# PubChem_Substance_ID:
46508800

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00511

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@@H](CC(O)=O)C(=O)O[P@@](O)(=O)OC[C@@H]1O[C@H]([C@H](O)[C@H]1O)N1C=NC2=C1N=CN=C2N

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:35 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X70943

# Drug_Target_1_GenBank_ID_Protein:
396501

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
aspS

# Drug_Target_1_Gene_Sequence:
>1743 bp
ATGCGTCGCACCCACTACGCCGGAAGCCTGAGGGAAACCCACGTGGGCGAGGAGGTGGTC
CTCGAGGGCTGGGTCAACCGCCGCCGCGACCTCGGCGGCCTCATCTTCCTGGACCTCAGG
GACCGGGAGGGCCTGGTCCAGCTCGTGGCCCACCCCGCTAGCCCCGCCTACGCCACCGCC
GAACGGGTGCGCCCCGAGTGGGTGGTGCGGGCCAAAGGCCTCGTGCGCCTCCGCCCCGAG
CCCAACCCCCGCCTCGCCACGGGGCGGGTGGAGGTGGAGCTCTCTGCCCTCGAGGTCCTC
GCCGAGGCCAAGACGCCCCCCTTCCCCGTGGACGCGGGCTGGCGGGGGGAGGAGGAGAAG
GAGGCAAGTGAGGAGCTCCGCCTCAAGTACCGCTACCTGGACCTAAGAAGGCGGCGCATG
CAGGAGAACCTGCGCCTGCGCCACCGGGTCATCAAGGCCATCTGGGACTTCCTGGACCGG
GAGGGCTTCGTCCAGGTGGAAACCCCCTTTCTCACCAAAAGCACCCCGGAAGGGGCCCGG
GACTTCCTGGTGCCCTACCGCCACGAGCCCGGCCTCTTCTACGCCCTGCCCCAGTCCCCC
CAGCTCTTCAAGCAGATGCTGATGGTGGCGGGGCTGGACCGCTACTTCCAGATCGCCCGC
TGCTTCCGGGACGAGGACCTCCGCGCCGACCGCCAGCCCGACTTCACCCAGCTGGACCTG
GAGATGAGCTTCGTGGAGGTGGAGGACGTCCTGGAACTCAACGAGCGCCTCATGGCCCAC
GTCTTCCGCGAGGCGTTGGGGGTGGAGCTTCCCCTCCCCTTCCCCCGGCTTTCCTACGAG
GAGGCCATGGAGCGCTACGGCTCCGACAAGCCCGACCTCCGCTTCGGCCTGGAGCTCAAG
GAGGTGGGCCCCCTCTTCCGCCAAAGCGGCTTCAGGGTCTTCCAGGAGGCGGAAAGCGTG
AAGGCCCTTGCCCTCCCCAAGGCCCTCTCCCGCAAGGAGGTCGCCGAGCTGGAGGAGGTG
GCCAAGCGCCACAAGGCCCAGGGCCTCGCCTGGGCCCGGGTGGAGGAGGGGGGGTTTTCC
GGGGGTGTGGCCAAGTTTTTAGAACCCGTGCGGGAAGCTCTGCTCCAAGCCACGGAGGCC
AGGCCCGGGGACACCCTCCTCTTCGTGGCGGGGCCCCGCAAGGTGGCGGCCACGGCCCTG
GGGGCGGTGCGGCTTAGGGCGGCGGACCTTTTGGGCCTCAAGCGGGAGGGCTTCCGCTTC
CTCTGGGTGGTGGACTTTCCCCTTTTGGAGTGGGACGAGGAGGAGGAGGCCTGGACCTAC
ATGCACCACCCCTTCACGAGCCCCCACCCCGAGGACCTGCCCCTCCTGGAAAAGGACCCG
GGGAGGGTGCGGGCCTTGGCCTACGACCTCGTCCTCAACGGGGTGGAGGTGGGCGGGGGG
TCCATCCGCATCCACGACCCCAGGCTCCAGGCCCGGGTCTTCCGGCTTCTCGGCATCGGC
GAGGAGGAGCAAAGGGAGAAGTTCGGGTTCTTCCTCGAGGCCCTGGAGTACGGGGCCCCG
CCCCACGGGGGGATCGCCTGGGGGCTGGACCGCCTCCTCGCCCTCATGACGGGAAGCCCC
TCCATCCGCGAGGTCATCGCCTTCCCCAAGAACAAGGAAGGCAAGGACCCCCTGACCGGC
GCCCCGAGCCCCGTGCCCGAGGAGCAGCTTAGGGAGCTCGGCCTCATGGTGGTCCGGCCA
TGA

# Drug_Target_1_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_1_General_References:
10843857	Briand C, Poterszman A, Eiler S, Webster G, Thierry J, Moras D: An intermediate step in the recognition of tRNA(Asp) by aspartyl-tRNA synthetase. J Mol Biol. 2000 Jun 16;299(4):1051-60.
8045252	Delarue M, Poterszman A, Nikonov S, Garber M, Moras D, Thierry JC: Crystal structure of a prokaryotic aspartyl tRNA-synthetase. EMBO J. 1994 Jul 15;13(14):3219-29.
8319804	Poterszman A, Plateau P, Moras D, Blanquet S, Mazauric MH, Kreutzer R, Kern D: Sequence, overproduction and crystallization of aspartyl-tRNA synthetase from Thermus thermophilus. Implications for the structure of prokaryotic aspartyl-tRNA synthetases. FEBS Lett. 1993 Jul 5;325(3):183-6.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2425

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
66031

# Drug_Target_1_Name:
Aspartyl-tRNA synthetase

# Drug_Target_1_Number_of_Residues:
580

# Drug_Target_1_PDB_ID:
1L0W

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00152	tRNA-synt_2
PF01336	tRNA_anti
PF02938	GAD

# Drug_Target_1_Protein_Sequence:
>Aspartyl-tRNA synthetase
MRRTHYAGSLRETHVGEEVVLEGWVNRRRDLGGLIFLDLRDREGLVQLVAHPASPAYATA
ERVRPEWVVRAKGLVRLRPEPNPRLATGRVEVELSALEVLAEAKTPPFPVDAGWRGEEEK
EASEELRLKYRYLDLRRRRMQENLRLRHRVIKAIWDFLDREGFVQVETPFLTKSTPEGAR
DFLVPYRHEPGLFYALPQSPQLFKQMLMVAGLDRYFQIARCFRDEDLRADRQPDFTQLDL
EMSFVEVEDVLELNERLMAHVFREALGVELPLPFPRLSYEEAMERYGSDKPDLRFGLELK
EVGPLFRQSGFRVFQEAESVKALALPKALSRKEVAELEEVAKRHKAQGLAWARVEEGGFS
GGVAKFLEPVREALLQATEARPGDTLLFVAGPRKVAATALGAVRLRAADLLGLKREGFRF
LWVVDFPLLEWDEEEEAWTYMHHPFTSPHPEDLPLLEKDPGRVRALAYDLVLNGVEVGGG
SIRIHDPRLQARVFRLLGIGEEEQREKFGFFLEALEYGAPPHGGIAWGLDRLLALMTGSP
SIREVIAFPKNKEGKDPLTGAPSPVPEEQLRELGLMVVRP

# Drug_Target_1_Reaction:
ATP + L-aspartate + tRNAAsp = AMP + diphosphate + L-aspartyl-tRNAAsp

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
ATP + L-aspartate + tRNA(Asp) = AMP + diphosphate + L-aspartyl-tRNA(Asp)

# Drug_Target_1_SwissProt_ID:
P36419

# Drug_Target_1_SwissProt_Name:
SYD_THETH

# Drug_Target_1_Synonyms:
AspRS
Aspartate--tRNA ligase
EC 6.1.1.12

# Drug_Target_1_Theoretical_pI:
5.89

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB01895
